Gastric cancer is a major world health problem. It ranks as one of the biggest causes of cancer deaths globally, and it is no less of a problem in the United States. Internationally, gastric cancer is a top-five cause of cancer death in several countries, and it ranks in the top ten causes in others, including the U.S. It causes more deaths each year than breast, prostate, or colorectal cancer, and it causes almost as many deaths as liver cancer. Pathologists working by hand take a long time to perform analyses, and these analyses can vary quite a bit from one observer to another. The work is also quite prone to error, especially when trying to detect changes that are just beginning to occur and that don’t have a well-defined morphology. Over the past few years, a change has been seen in the force that transformed the medical imaging domain into a new era. This change and transformation are led by artificial intelligence, specifically deep learning. This study investigates how forceful and effective a CNN-based AI model can be when it comes to applying it to automatically detect gastric cancer, specifically from histopathological images. A publicly available dataset containing 5,000 labeled images (2,500 cancerous and 2,500 normal) was the basis for designing a robust AI pipeline that involves image preprocessing, augmentation, and training a custom deep CNN architecture. The steps taken before processing included color normalization, Gaussian filtering, and contrast enhancement. These were done to ensure image quality was consistent and that the histological features the researchers were interested in were visible. Diversity in the dataset was greatly enhanced, and the generalization of the model improved, by using several augmentation techniques. We trained and validated the CNN model with a split that was not only stratified, but also sensible—70% for training, 15% for validation, and 15% for testing. The model achieved several impressive performance parameters upon testing, including a classification accuracy of 94.8%, sensitivity of 93.5%, specificity of 96.1%, and an area under the ROC curve (AUC) of 0.972. Our results confirm the assumption that AI, and more specifically CNNs, can not only equal but may even exceed the performance metrics of traditional diagnostics in histopathological evaluation. Using Grad-CAM visualizations, we showed that the model did a good job of homing in on the important distinguishing features of malignancy, like cellular atypia and glandular irregularities. This not only speaks to the model’s effectiveness but also to its interpretability and transparency. Affirmative, the basic machine learning algorithms, such as Support Vector Machines and Random Forests, serve well as baselines for comparison. But deep learning demonstrates its power and supremacy in the field of complex image-based tasks when it’s stacked against those basic algorithms. Combining AI with histopathology work could speed up the overall workflow, lightening the pathologist’s load and, we hope, leading to faster and more accurate diagnoses. This, in turn, could lead to increased patient survival and improved outcomes. In addition, the unchanging and impartial nature of AI-powered analysis offers a solid basis for large-scale implementation in clinical environments. This study highlights the ability of AI to transform digital pathology and paves the way for subsequent advances. These advances may include the classification of multiple types of gastric cancer, the real-time application of AI technologies in pathology labs, and the integration of these technologies into explainable, clinically trustworthy frameworks.